Compounded Pain Management: Beyond Commercial Limitations

The opioid crisis has driven a critical re-evaluation of pain management strategies, with growing emphasis on non-opioid alternatives and targeted delivery methods. Compounded pain management formulations offer a powerful tool for physicians seeking to address pain at multiple receptor sites while minimizing systemic exposure and associated risks.

Topical compounded pain preparations can combine multiple active ingredients — such as ketamine, gabapentin, diclofenac, cyclobenzaprine, and lidocaine — in a single transdermal formulation. This multimodal approach targets pain through several mechanisms simultaneously, often achieving better results than single-agent therapy.

Advantages of compounded pain formulations include: targeted local delivery reducing systemic side effects, combination of multiple agents in a single application, customizable ingredient concentrations, alternative to systemic opioid therapy, and various delivery options (topical, nasal, oral).

NuvexaPharmRx offers a comprehensive formulary of pain management compounds, with our pharmacists available to consult with prescribers on optimal formulation selection for specific pain conditions.